Oral Food Challenge for Food Intolerance
(INFINITY Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores a new method to diagnose food protein-induced enterocolitis syndrome (FPIES), a condition that causes severe digestive reactions to certain foods. The researchers aim to determine the optimal dose for a low-dose, multi-day oral food challenge, which involves gradually consuming small amounts of food to observe if symptoms are triggered. Participants will test different doses of food protein, either at home (At-Home Low-Dose Oral Food Challenge) or under supervision (Supervised High-Dose Oral Food Challenge or Supervised Low-Dose Oral Food Challenge). This trial suits individuals aged 1-60 who have previously experienced an FPIES reaction and can identify symptoms like severe vomiting or diarrhea after consuming certain foods. As an unphased trial, this study provides a unique opportunity to contribute to groundbreaking research in diagnosing FPIES.
Will I have to stop taking my current medications?
The trial requires participants to stop taking certain medications for 7 days before the screening visit and throughout the study, unless they are needed as rescue medications.
What prior data suggests that this protocol is safe for diagnosing FPIES?
Research has shown that oral food challenges (OFCs) are generally safe for diagnosing food allergies. An OFC involves consuming small amounts of the suspected food allergen under medical supervision to monitor for reactions. Studies have found that low-dose OFCs are particularly well-tolerated. In one study, infants under one year safely consumed small amounts of allergenic foods without severe reactions.
The supervised high-dose OFC is also considered safe, though the risk of a reaction increases with the larger amount of allergen. Medical staff are present to manage any reactions that may occur during these tests.
Overall, while reactions can occur, they are usually mild and manageable. The medical team ensures participants' safety throughout the process.12345Why are researchers excited about this trial?
Researchers are excited about the Oral Food Challenge (OFC) trial for food intolerance because it explores different approaches to manage and potentially improve food tolerance in a controlled and measured way. Unlike standard treatments that often involve strict avoidance or gradual introduction of allergens, this trial is testing various doses of food proteins to see how they can be safely reintroduced. The trial includes both at-home low-dose and supervised high-dose challenges, which could offer more flexibility and insight into personalized treatment plans for individuals with food intolerances. By examining how different doses affect tolerance, the trial may pave the way for more tailored, effective strategies to manage food intolerance, ultimately improving patient quality of life.
What evidence suggests that this trial's treatments could be effective for diagnosing food protein-induced enterocolitis syndrome?
Research has shown that oral food challenges (OFCs) reliably test for food allergies, including food protein-induced enterocolitis syndrome (FPIES). These tests diagnose food allergies by gradually introducing the suspected allergen and observing any reactions. In this trial, participants will undergo various types of OFCs. Some will take part in at-home low-dose OFCs, which studies recommend for safely diagnosing food allergies, as they provide crucial information about a person's sensitivity to certain foods. Others will participate in supervised high-dose OFCs, which are valuable for helping patients learn about and manage their food allergies. These methods enable doctors to better understand the severity and management of food allergies.14678
Who Is on the Research Team?
Anna Nowak-Wegrzyn, MD, PhD
Principal Investigator
NYU Langone Health
Are You a Good Fit for This Trial?
This trial is for individuals aged 1-60 with suspected or confirmed food protein-induced enterocolitis syndrome (FPIES), a condition causing digestive distress after eating certain foods. Details on who can't join are not provided.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline
Participants complete a baseline gastrointestinal symptom diary
Low Dose Oral Food Challenge
Participants undergo a supervised Low Dose OFC to their FPIES trigger
Home Challenge
Participants who do not react at the Day 1 Low Dose OFC continue with a daily home challenge
High Dose Oral Food Challenge
Participants who tolerated the home challenges undergo a High Dose OFC
Follow-up
Participants are monitored for safety and effectiveness after the challenges
What Are the Treatments Tested in This Trial?
Interventions
- At-Home Low-Dose Oral Food Challenge
- Supervised High-Dose Oral Food Challenge
- Supervised Low-Dose Oral Food Challenge
Find a Clinic Near You
Who Is Running the Clinical Trial?
NYU Langone Health
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Collaborator